Related Experiment Videos
Targets for current pharmacologic therapy in cholesterol gallstone disease
Agostino Di Ciaula1, David Q H Wang, Helen H Wang
1Division of Internal Medicine, Hospital of Bisceglie, Bisceglie (Bari), Italy.
Gastroenterology Clinics of North America
|May 19, 2010
Summary
Gallstone disease, primarily cholesterol stones, affects many worldwide. New medical therapies, including cholesterol-lowering drugs, offer potential alternatives to surgery for select patients.
Area of Science:
- Gastroenterology
- Hepatology
- Pharmacology
Background:
- Gallstone disease is prevalent globally, with cholesterol stones being most common in Western nations.
- Laparoscopic cholecystectomy is the standard surgical treatment for symptomatic gallstones.
- Patient selection for non-surgical medical therapy requires careful consideration of disease natural history and treatment costs.
Purpose of the Study:
- To review current perspectives on the medical treatment of cholesterol gallstone disease.
- To explore novel therapeutic agents and strategies for cholesterol gallstone management.
- To identify patient subgroups suitable for non-surgical interventions.
Main Methods:
- Review of recent studies on medical therapies for cholesterol gallstones.
- Analysis of drugs targeting cholesterol metabolism and bile acid homeostasis.
- Discussion of patient selection criteria for oral litholysis.
Main Results:
- Ursodeoxycholic acid is used for oral litholysis in specific patients with small, uncalcified cholesterol gallstones.
- Cholesterol-lowering agents (statins, ezetimibe) and nuclear receptor modulators show promise.
- Combination therapies may offer additional medical treatment options.
Conclusions:
- Medical management of cholesterol gallstones is evolving with new pharmacological approaches.
- Careful patient selection remains crucial for successful non-surgical treatment.
- Further research into novel agents and combination therapies is warranted.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...